Company
Headquarters: Tokyo, Japan
Employees: 1,546
CEO: Mr. Toshimichi Ohno
¥7.08 Billion
JPY as of July 1, 2024
US$43.9 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Pharmarise Holdings Corp has the following listings and related stock indices.
Stock: JPX: 2796 wb_incandescent